Osteochondral Lesion of Talus
12
2
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (12)
Autologous Osteoperiosteal Transplantation for the Treatment of Severe Osteochondral Lesions of the Talus
Microfracture With Platelet Rich Plasma Gel Injection for Osteochondral Lesion of the Talus
AMIC vs. MFx in the Ankle
Monitoring of Weight Bearing Protocols Via Mobile Application and Pressure Sensors.
Clinical Outcome of Surgical Treatment for Osteochondral Lesions of the Talus
Osteochondral Lesions Under 15mm2 of the Talus; is Iliac Crest Bone Marrow Aspirate Concentrate the Key to Success?
Treatment Outcome After Ankle Joint Surgeries
Extracorporeal Shock Wave Therapy for Pain-Relief After Arthroscopy for Osteochondral Lesions of the Talus
Microfracture vs. Microfracture and BMAC for Osteochondral Lesions of the Talus
DeNovo NT Ankle LDC Study
Clinical and Radiological Results of Osteochondral Repair Using MaioRegen in Knee and Ankle Surgery
Safety and Efficacy of Allogenic Umbilical Cord Blood-derived Mesenchymal Stem Cell Product